Samuel J Reich
CIK 1394645 · CEO · last filed 2026-02-05
Samuel J Reich is a CEO who has filed 14 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for SABSW, was dated Feb 5, 2026. Across all open-market trades the lifetime net is +$4.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $9.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.7K
3
14
$4.19M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SABSW | CEO | 766,699 | $0.01 | $9.7K | $9.8K | 11 | 2026-02-05 |
| SAB Biotherapeutics, Inc. (BCYPW) Delisted | CEO and CFO | 3,048,825 | $1.10 | $3.35M | $10.1K | 1 | 2021-10-15 |
| SAB Biotherapeutics, Inc. (BCYPU) Delisted | CEO and CFO | 3,047,825 | $8.57 | $26.12M | $4.17M | 1 | 2021-01-14 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-05 | SABSW | Grant (A) | — | $0 | EDGAR |
| 2025-08-28 | SABSW | Grant (A) | — | $0 | EDGAR |
| 2024-07-17 | SABSW | Grant (A) | — | $0 | EDGAR |
| 2024-02-23 | SABSW | Grant (A) | — | $0 | EDGAR |
| 2023-11-30 | SABSW | Buy (P) | +11,000 | $9.8K | EDGAR |
| 2023-03-16 | SABSW | Grant (A) | — | $0 | EDGAR |
| 2023-03-02 | SABSW | Other (J) | — | $0 | EDGAR |
| 2022-09-15 | SABSW | Grant (A) | — | $0 | EDGAR |
| 2022-05-23 | SABSW | Other (J) | −2,293,126 | $0 | EDGAR |
| 2022-03-18 | SABSW | Grant (A) | — | $0 | EDGAR |